Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus

Surgery Today

Volumn 27, Issue 8, 1997, Pages 685-691

  Koide, Naohiko ^a   Koike, Shoichiro ^a   Adachi, Wataru ^a   Amano, Jun ^a   Usuda, Nobuteru ^a   Nagata, Tetsuji ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Basaloid carcinoma; bcl 2 protein; Esophageal carcinoma

Indexed keywords

PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; LYMPH NODE METASTASIS; METABOLISM; MORTALITY; PATHOLOGY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE;

EID: 0030612529     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02384977     Document Type: Article

References (30)

1. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistake in VDJ jointing. Science 229:1390-1393
2. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ (1985) Cloning the chromosomal breakpoint of t(14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899-906
3. Cleary ML, Sklar J (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443
4. Cleary ML, Smith SD, Sklar J (1986) Cloning and structual analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunogloblin transcript resulting from the t(14;18) translocation. Cell 47:19-28
5. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ (1988) Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J 7:123-131
6. Chen-Levy Z, Nourse J, Cleary ML (1989) The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14:18) translocation. Mol Cell Biol, 9:701-710
7. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336
8. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442
9. Nunez G, London L, Hockenbery D, Alexander M, Mckearn JP, Korsmeyer SJ (1990) Deregulated hcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell fines. J Immunol 144:3602-3610
10. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ (1991) Bcl2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965
11. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY (1993) bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694
12. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R (1993) Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Path 143:390-400
13. Castle VP, Heidelberger KP. Bromberg J, Ou X, Dole M, Nunez G (1993) Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143:1543-1550
14. Japanese Society for Esophageal Disease (1992) Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, 8th edn. Kanehara, Tokyo
15. Hsu SM, Raine L, Fanger H (1981) A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying peptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734-738
16. Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR (1993) Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in folmalin-fixed paraffin sections. J Histochem Cytochem 41:1599-1640
17. Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, Key G, D'Amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F (1993) Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171:83-98
18. Pezzella F, Tse AGD, Gordell JL, Pulford KAF, Gatter KC, Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14:18 chromosomal translocation. Am J Path 137:225-232
19. Koide N (1994) Histochemical study on cell proliferation and cell death in esophageal carcinoma (in Japanese with English abstract). Shinshu Med J 42:378-388
20. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
21. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M, Viale G (1994) The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 424:47-51
22. Yunis JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken MM, Frizzera G (1989) bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Eng J Med 320:1047-1054
23. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP, Guyotat D (1993) High expression of bcl-2 protein in acute myeloid leuchemia cells in associated with poor response to chemotherapy. Blood 81:3091-3096
24. Piris MA, Pezela F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Garrido MC, Gatter K, Aiello A, Delia D, Giardini R, Rilke F (1994) p53 and bcl-2 expression in high grade B-cell lymphomas: correlation with survival time. Br J Cancer 69:337-341
25. Lipponen P, Eskelinen M, Syrajanen K (1995) Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br J Cancer 71:863-867
26. Mustard RA, Ibberson O (1956) Carcinoma of the esophagus. A review of 381 cases admitted to Toronto General Hospital 1937-1953 inclusive. Ann Surg 144:927-940
27. Suzuki H, Nagayo T (1980) Primary tumors of the esophagus other than squamous cell carcinoma: Histologic classification and statistics in the surgical and autopsied materials in Japan. Int Adv Surg Oncol 3:73-109
28. Gowing NFC (1961) The pathology of the oesophagus tumours. In: Tanner NC, Smith DW (eds) Tumours of the oesophagus. Livingstone, Edinburgh, pp 91-135
29. McKay MJ, Bilous AM (1989) Basaloid-squamous cell carcinoma of the hypopharynx. Cancer 63:2528-2531
30. Takubo K, Mafune K, Tanaka Y, Miyama T, Fujita K (1991) Basaloid-squamous carcinoma of the esophagus with marked deposition of basement membrane substance. Acta Pathol Jpn 41:59-64